The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients
Official Title: Vedio-assisted Thoracoscopic Lobectomy vs Open Lobectomy for Patients With Surgically Resectable Pathologic N2 NSCLC
Study ID: NCT03613467
Brief Summary: The study was designed to compare the safety and effectiveness of vedio-assisted thoracoscopic lobectomy with open lobectomy for patients with surgically resectable pathologic N2 non-small cell lung cancer
Detailed Description: The is a multi-center retrospective study. Patients with pathologic N2 NSCLC who underwent VATS or open lobectomy between 2014 and 2017 were included into this study. Clinical data on patient demographic, clinical characteristics, treatment and clinical outcomes will be collected to evaluate the safety and effectiveness of video-assisted thoracoscopic lobectomy for pathologic N2 NSCLC.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
China-Japan Friendship Hospital, Beijing, Beijing, China
China PLA General Hospital, Beijing, Beijing, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Tongji Hospital Affiliated to Huazhong Technology Hospital, Wuhan, Hubei, China
Jiangsu cancer hospital, Nanjing, Jiangsu, China
Xi'an Tangdu Hospital, Xi'an, Shaanxi, China
Shanghai Chest Hospital, Shanghai, Shanghai, China
Huaxi Hospital Affiliated to Sichuan University, Chengdu, Sichuan, China
Tianjin Chest Hospital, Tianjin, Tianjin, China
First Hospital Affiliated to Zhejiang University, Hangzhou, Zhejiang, China
Name: Xiaofei Li, PhD
Affiliation: Tang-Du Hospital
Role: PRINCIPAL_INVESTIGATOR